Covid-19 : Guidance on more regulatory flexibility for medicines
Regulatory

Covid-19 : Guidance on more regulatory flexibility for medicines

The European Commission, EMA and the European medicines regulatory network have
developed a Q&A document to provide guidance to stakeholders on adaptations to the
regulatory framework to address challenges arising from the COVID-19 pandemic,
with a particular focus on crucial medicines for use in COVID-19 patients.

Read more
The new challenges of injectable medicines
La Vague 65

The new challenges of injectable medicines
April 2020 La Vague #65 Cleaning validation + Combination Products Download the issue Summary ✻ Injectable Combination Products. Issues and challenges for industry. Deadline Extension or Not: Key Points for [...]
Read more
In order to offer the best possible service, A3P uses cookies. By continuing to browse this website, you confirm to agree with their use.
I agree - Find out more
LINK10
Copy this code in your event registration form to receive an exclusive gift upon your arrival!
This code must be copied in the "Additional Information" field in the event registration form:
Additionnal Information